INSPECS Group (SPEC) Competitors

GBX 71.50
-2.50 (-3.38%)
(As of 05/13/2024 ET)

SPEC vs. BVC, TSTL, POLB, EAH, DXRX, CEL, REDX, SCLP, ETX, and AGL

Should you be buying INSPECS Group stock or one of its competitors? The main competitors of INSPECS Group include BATM Advanced Communications (BVC), Tristel (TSTL), Poolbeg Pharma (POLB), ECO Animal Health Group (EAH), Diaceutics (DXRX), Celadon Pharmaceuticals (CEL), Redx Pharma (REDX), Scancell (SCLP), e-therapeutics (ETX), and ANGLE (AGL). These companies are all part of the "medical" sector.

INSPECS Group vs.

BATM Advanced Communications (LON:BVC) and INSPECS Group (LON:SPEC) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations, earnings, community ranking and media sentiment.

BATM Advanced Communications pays an annual dividend of GBX 1 per share and has a dividend yield of 5.2%. INSPECS Group pays an annual dividend of GBX 1 per share and has a dividend yield of 1.4%. INSPECS Group pays out -10,000.0% of its earnings in the form of a dividend.

41.8% of BATM Advanced Communications shares are owned by institutional investors. Comparatively, 67.0% of INSPECS Group shares are owned by institutional investors. 26.2% of BATM Advanced Communications shares are owned by company insiders. Comparatively, 25.6% of INSPECS Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
INSPECS Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

BATM Advanced Communications has a beta of 0.55, suggesting that its stock price is 45% less volatile than the S&P 500. Comparatively, INSPECS Group has a beta of 2.16, suggesting that its stock price is 116% more volatile than the S&P 500.

BATM Advanced Communications has a net margin of -0.16% compared to BATM Advanced Communications' net margin of -0.49%. INSPECS Group's return on equity of -0.17% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-0.16% -0.17% 0.25%
INSPECS Group -0.49%-0.94%0.79%

BATM Advanced Communications received 185 more outperform votes than INSPECS Group when rated by MarketBeat users. However, 100.00% of users gave INSPECS Group an outperform vote while only 49.48% of users gave BATM Advanced Communications an outperform vote.

CompanyUnderperformOutperform
BATM Advanced CommunicationsOutperform Votes
190
49.48%
Underperform Votes
194
50.52%
INSPECS GroupOutperform Votes
5
100.00%
Underperform Votes
No Votes

BATM Advanced Communications has higher earnings, but lower revenue than INSPECS Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£122.83M0.68£2.51MN/AN/A
INSPECS Group£203.29M0.36-£1.19M-£0.01-7,150.00

In the previous week, BATM Advanced Communications had 2 more articles in the media than INSPECS Group. MarketBeat recorded 2 mentions for BATM Advanced Communications and 0 mentions for INSPECS Group. INSPECS Group's average media sentiment score of 0.87 beat BATM Advanced Communications' score of 0.00 indicating that BATM Advanced Communications is being referred to more favorably in the media.

Company Overall Sentiment
BATM Advanced Communications Positive
INSPECS Group Neutral

Summary

BATM Advanced Communications beats INSPECS Group on 10 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SPEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SPEC vs. The Competition

MetricINSPECS GroupMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£72.69M£2.75B£4.98B£1.53B
Dividend Yield2.00%1.90%39.25%11.97%
P/E Ratio-7,150.00330.10161.301,716.87
Price / Sales0.36200.182,363.37337,276.12
Price / Cash1.63121.9032.8832.85
Price / Book0.703.214.972.57
Net Income-£1.19M£93.20M£103.57M£184.84M
7 Day Performance16.02%1.36%-0.55%6.09%
1 Month Performance45.92%-1.59%-0.91%2.81%
1 Year Performance-45.21%-2.84%5.13%9.78%

INSPECS Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BVC
BATM Advanced Communications
0 of 5 stars
GBX 18.52
-6.2%
N/A-26.2%£80.77M£122.83M2,800.00980Positive News
TSTL
Tristel
0.09 of 5 stars
GBX 445.75
-0.9%
GBX 390
-12.5%
+35.9%£211.82M£39.49M3,714.58208
POLB
Poolbeg Pharma
0 of 5 stars
GBX 14.12
-5.2%
N/A+78.8%£70.60MN/A-1,412.0012Gap Down
EAH
ECO Animal Health Group
0 of 5 stars
GBX 119.98
+6.6%
N/A-2.5%£81.27M£88.46M-5,998.75234Gap Up
DXRX
Diaceutics
0 of 5 stars
GBX 97.85
+0.4%
GBX 150
+53.3%
+1.0%£82.86M£21.90M10,500.00151
CEL
Celadon Pharmaceuticals
0 of 5 stars
GBX 98.16
-3.3%
GBX 222.50
+126.7%
-25.0%£63.03M£11,258.00-755.0824News Coverage
Gap Down
REDX
Redx Pharma
0 of 5 stars
GBX 15
+31.6%
N/A-55.2%£58.35M£4.20M-150.00101Gap Up
High Trading Volume
SCLP
Scancell
0 of 5 stars
GBX 9.73
+3.5%
N/A-37.3%£90.23M£5.27M-972.5051
ETX
e-therapeutics
0 of 5 stars
GBX 9.30
-3.6%
N/A-29.3%£54.34M£295,000.00-465.0034
AGL
ANGLE
0.9033 of 5 stars
GBX 19.70
-7.3%
GBX 70
+255.3%
+1.2%£51.34M£1.82M-218.90173Gap Up

Related Companies and Tools

This page (LON:SPEC) was last updated on 5/14/2024 by MarketBeat.com Staff

From Our Partners